Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Free Report

White Paper_2017_State of China Life Science

State of China Life Science - 2017H1

Over $10B invested in last 18 months! Download free report on life science investment in China.

Top Stories

Recent articles that are of ongoing interest...

Shanghai Henlius Announces $192.5 Million Funding for Biosimilars, Novel mAbs
Shanghai's SARI to Acquire NMS, an Italian Oncology Company, for $359 Million
CR Pharm Files for $368.5 Million China Pharma Fund
Zai Labs Completes $150 Million IPO; Stock Jumps 50% at Opening; Company Worth $1.4 Billion
Shanghai United Imaging Healthcare Raises Record $500 Million at $5 Billion Valuation
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China